AngioDynamics to Present at the J.P. Morgan Healthcare Conference

LATHAM, N.Y.--()--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Sr. Vice President, General Counsel, and Interim Chief Financial Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference at 8:00 a.m. PT on Thursday, January 16, 2020 in San Francisco, CA.

A live webcast of the presentation and Q&A breakout session will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following the event.

About AngioDynamics, Inc.

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products, and venous products. For more information, visit www.angiodynamics.com.

Contacts

Investor Contact:
AngioDynamics, Inc.
Stephen Trowbridge, Sr. Vice President, General Counsel & Interim CFO
(518) 795-1408

Contacts

Investor Contact:
AngioDynamics, Inc.
Stephen Trowbridge, Sr. Vice President, General Counsel & Interim CFO
(518) 795-1408